1. Home
  2. VALN vs CBL Comparison

VALN vs CBL Comparison

Compare VALN & CBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VALN
  • CBL
  • Stock Information
  • Founded
  • VALN 2012
  • CBL 1978
  • Country
  • VALN France
  • CBL United States
  • Employees
  • VALN N/A
  • CBL N/A
  • Industry
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • CBL Real Estate Investment Trusts
  • Sector
  • VALN Health Care
  • CBL Real Estate
  • Exchange
  • VALN Nasdaq
  • CBL Nasdaq
  • Market Cap
  • VALN 820.0M
  • CBL 938.8M
  • IPO Year
  • VALN 2021
  • CBL 1993
  • Fundamental
  • Price
  • VALN $9.43
  • CBL $33.25
  • Analyst Decision
  • VALN Strong Buy
  • CBL
  • Analyst Count
  • VALN 4
  • CBL 0
  • Target Price
  • VALN $15.75
  • CBL N/A
  • AVG Volume (30 Days)
  • VALN 21.9K
  • CBL 137.8K
  • Earning Date
  • VALN 11-20-2025
  • CBL 11-06-2025
  • Dividend Yield
  • VALN N/A
  • CBL 5.38%
  • EPS Growth
  • VALN N/A
  • CBL 297.30
  • EPS
  • VALN N/A
  • CBL 4.02
  • Revenue
  • VALN $211,089,992.00
  • CBL $553,643,000.00
  • Revenue This Year
  • VALN $6.86
  • CBL N/A
  • Revenue Next Year
  • VALN $11.85
  • CBL N/A
  • P/E Ratio
  • VALN N/A
  • CBL $8.33
  • Revenue Growth
  • VALN 13.48
  • CBL 5.74
  • 52 Week Low
  • VALN $3.62
  • CBL $21.10
  • 52 Week High
  • VALN $12.25
  • CBL $33.54
  • Technical
  • Relative Strength Index (RSI)
  • VALN 56.66
  • CBL 66.70
  • Support Level
  • VALN $8.53
  • CBL $32.52
  • Resistance Level
  • VALN $8.92
  • CBL $33.31
  • Average True Range (ATR)
  • VALN 0.33
  • CBL 0.77
  • MACD
  • VALN 0.07
  • CBL 0.09
  • Stochastic Oscillator
  • VALN 89.57
  • CBL 91.29

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

About CBL CBL & Associates Properties Inc.

CBL & Associates Properties Inc is a real estate investment trust. The company engages in the ownership, development, acquisition, leasing, management and operation of regional shopping malls, outlet centers, lifestyle centers, open-air centers and other properties. CBL's sales predominantly derive from leasing arrangements with retail tenants. The company also generates revenue from management and development fees, as well as sales of its real estate assets. CBL expands its portfolio of assets through activities such as redevelopment, renovation, and expansion.

Share on Social Networks: